Chapter 43: Antibiotics Part 1 – Penicillins, Cephalosporins & Macrolides

The study of antimicrobial agents begins with the general principles of infectious disease management, covering the distinctions between community-acquired and health care–associated infections, the latter of which are often highly drug-resistant (such as MRSA and VRE). This chapter details the foundational concepts of antibiotic therapy, including empiric therapy (presumptive treatment before organism identification), targeted therapy (based on culture results), and prophylactic therapy (preventative use), emphasizing the necessity of obtaining culture specimens before initiating antibiotic administration. The core challenge addressed is antimicrobial resistance, which is exacerbated by the misuse of broad-spectrum drugs and patients failing to complete their prescribed regimen, frequently resulting in serious secondary infections like Clostridium difficile superinfection. Antibiotics are classified based on their actions—either bactericidal (killing bacteria) or bacteriostatic (inhibiting growth)—and employ four primary mechanisms, such as interfering with bacterial cell wall synthesis or inhibiting protein synthesis. Five major classes are examined: Sulfonamides act as bacteriostatic antimetabolites by blocking bacterial folic acid synthesis, but they necessitate high fluid intake to prevent crystalluria and are associated with severe allergic reactions like Stevens-Johnson syndrome. Beta-lactam antibiotics (Penicillins, Cephalosporins, Carbapenems, Monobactams) are generally bactericidal inhibitors of cell wall synthesis; Penicillins are known for a high allergy risk and often require beta-lactamase inhibitors (like clavulanic acid) to counter resistance. Cephalosporins, organized into five generations, offer increasingly potent coverage against Gram-negative bacteria, requiring careful assessment for cross-sensitivity in patients with penicillin allergies. Macrolides (e.g., azithromycin, erythromycin) are primarily bacteriostatic, inhibiting protein synthesis and are effective against specific respiratory and intracellular pathogens, though many macrolides carry a risk of significant drug-drug interactions through the cytochrome P450 system. Lastly, Tetracyclines are bacteriostatic protein synthesis inhibitors that are chemically notorious for their ability to chelate (bind) with metallic ions like calcium; this characteristic requires patients to avoid dairy and antacids and contraindicates their use in young children due to the risk of permanent tooth discoloration. The nursing process for these drugs requires rigorous baseline assessment of host factors (including age, organ function, and genetic factors like G6PD deficiency) and continuous monitoring for therapeutic efficacy and adverse effects.